Cyclacel Pharmaceuticals Files 8-K
Ticker: BGMSP · Form: 8-K · Filed: Jul 28, 2025 · CIK: 1130166
| Field | Detail |
|---|---|
| Company | Cyclacel Pharmaceuticals, INC. (BGMSP) |
| Form Type | 8-K |
| Filed Date | Jul 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, filing, financials
Related Tickers: CYCC
TL;DR
Cyclacel Pharma filed an 8-K on 7/28/25 for corporate updates and financials.
AI Summary
Cyclacel Pharmaceuticals, Inc. filed an 8-K on July 28, 2025, reporting amendments to its articles of incorporation or bylaws and financial statements. The company, previously known as Xcyte Therapies Inc. until December 18, 2000, is incorporated in Delaware and has its fiscal year end on December 31. Its principal executive offices are located at 200 Connell Drive, Suite 1500, Berkeley Heights, NJ.
Why It Matters
This filing indicates routine corporate updates and financial reporting for Cyclacel Pharmaceuticals, Inc., providing transparency to investors about the company's structure and financial status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting corporate amendments and financial statements, not indicating any immediate significant operational or financial distress.
Key Numbers
- 000-50626 — SEC File Number (Identifies the company's filing history with the SEC.)
- 91-1707622 — I.R.S. Employer Identification Number (Tax identification number for the company.)
Key Players & Entities
- Cyclacel Pharmaceuticals, Inc. (company) — Registrant
- XCYTE THERAPIES INC (company) — Former company name
- July 28, 2025 (date) — Date of Report
- December 18, 2000 (date) — Date of name change
- Delaware (jurisdiction) — State of incorporation
- 200 Connell Drive, Suite 1500, Berkeley Heights, NJ (address) — Business and mail address
FAQ
What specific amendments were made to Cyclacel Pharmaceuticals' articles of incorporation or bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What is the primary business of Cyclacel Pharmaceuticals, Inc.?
Cyclacel Pharmaceuticals, Inc. is in the 'PHARMACEUTICAL PREPARATIONS' industry, SIC code 2834.
When does Cyclacel Pharmaceuticals, Inc. observe its fiscal year end?
The company's fiscal year ends on December 31.
What was the former name of Cyclacel Pharmaceuticals, Inc. and when did the name change occur?
The company was formerly known as XCYTE THERAPIES INC, and the name change occurred on December 18, 2000.
Where are Cyclacel Pharmaceuticals, Inc.'s principal executive offices located?
The company's business and mail address is located at 200 Connell Drive, Suite 1500, Berkeley Heights, NJ.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 28, 2025 regarding Cyclacel Pharmaceuticals, Inc. (BGMSP).